Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advancesAyana R. Kumar, Javad Sharifi‐Rad, Bhagyalakshmi Nair et al.|European journal of medical research|2024Cited by 15
Unveiling the role of the Hedgehog signaling pathway in chronic liver disease: Therapeutic insights and strategiesBhagyalakshmi Nair, Lekshmi R. Nath, Adithya Jayaprakash Kamath et al.|Drug Discovery Today|2024Cited by 14
Mast cells and the gut-liver Axis: Implications for liver disease progression and therapyBhagyalakshmi Nair, Lekshmi R. Nath, Gautam Sethi et al.|Life Sciences|2024Cited by 13
Smart Polymer‐Based Delivery Systems for Curcumin in Colon Cancer Therapy: A ReviewAdithya Jayaprakash Kamath, Lekshmi R. Nath, Asawari Dilip Donadkar et al.|Phytotherapy Research|2024Cited by 9